Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multi-Drug Resistant Hiv-1 Infection”

16 trials

Showing 16 of 16 results

Not applicableLooking for participantsNCT06762054
What this trial is testing

Investigating the Optimal Management of Dolutegravir Resistance

Who this might be right for
HIV-1-infection
University of Nairobi 6,600
Testing effectiveness (Phase 2)UnknownNCT04560569
What this trial is testing

Albuvirtide in Combination With 3BNC117 in Patients With Multi-Drug Resistant (MDR) HIV-1 Infection

Who this might be right for
HIV/AIDS
Frontier Biotechnologies Inc. 20
Not applicableUnknownNCT00102934
What this trial is testing

Treatment Intensification for HIV Infected Patients With Multi-Drug Resistant Virus

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 20
Not applicableNot Yet RecruitingNCT06842706
What this trial is testing

Prevalence of Drug-resistant Hiv-1 Strains in Patients Experiencing Virologic Failure. (MULTIVIR2025)

Who this might be right for
HIV Infection
ANRS, Emerging Infectious Diseases 800
Post-approval studies (Phase 4)Study completedNCT04538040
What this trial is testing

Bictegravir/Emtricitabine/Tenofovir Alafenide Plus Doravirine

Who this might be right for
HIV-1-infection
Quest Clinical Research 20
Large-scale testing (Phase 3)Study completedNCT02707861
What this trial is testing

Ibalizumab Plus Optimized Background Regimen in Treatment-Experienced Patients With Multi-Drug Resistant HIV-1

Who this might be right for
HIV
TaiMed Biologics Inc. 79
Large-scale testing (Phase 3)Study completedNCT05349838
What this trial is testing

Open-Label Multi-Centre Randomised Switch Study to Evaluate Virological Efficacy Over 96Weeks Of 2-Drug Therapy With Dolutegravir(DTG)/Rilpivirine(RPV) Fixed Dose Combination(FDC) in Antiretroviral Treatment-Experienced HIV-1 Infected Subjects Virologically Suppressed With NNRTI Mutation K103N

Who this might be right for
HIV-1-infection
NEAT ID Foundation 140
Not applicableLooking for participantsNCT04098315
What this trial is testing

Italian Registry of HIV-1 Infected Patients With Drug-RESistant Virus to Reverse Transcriptase Inhibitors, InteGrasE and Viral Protease.

Who this might be right for
HIV-1-infectionMulti-Antiviral Resistance
Castagna Antonella 300
Not applicableStudy completedNCT00005915
What this trial is testing

A Comparison of Two Anti-HIV Treatment Plans

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 480
Large-scale testing (Phase 3)Not Yet RecruitingNCT04406727
What this trial is testing

UB-421 in Combination With Optimized Background Regimen in Patients With Multi-drug Resistant HIV-1 Infection

Who this might be right for
HIV-1 Infection
United BioPharma 50
Testing effectiveness (Phase 2)UnknownNCT03164447
What this trial is testing

UB-421 Combine With Optimized Background Therapy Regimen in Multi-Drug Resistant HIV-1 Infection Patients

Who this might be right for
HIV-1 Infection
United BioPharma 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT04648280
What this trial is testing

Safety and Pharmacokinetics Evaluation of Fostemsavir + (OBT) in HIV-1 Infected Children and Adolescents Who Are Failing Their cART and Have Dual- or Triple-class Antiretroviral Resistance

Who this might be right for
HIV Infections With Multi Drug Resistant Virus
PENTA Foundation 60
Large-scale testing (Phase 3)Study completedNCT03913195
What this trial is testing

Study of the Safety of Trogarzo™ Administered as an Undiluted "IV Push" or an Intramuscular Injection

Who this might be right for
HIV-1-infection
TaiMed Biologics Inc. 43
Testing effectiveness (Phase 2)WithdrawnNCT05582694
What this trial is testing

A Trial of Anti-CD4 Antibody UB-421 in Combination With Optimized Background Antiretroviral Therapy in Patients With Multi-Drug Resistant HIV-1 Infection

Who this might be right for
Multi-Drug Resistant Hiv-1 InfectionHIV-1 Infection
National Institute of Allergy and Infectious Diseases (NIAID)
Post-approval studies (Phase 4)Study completedNCT00187551
What this trial is testing

Pilot Study Evaluating Interruption of Enfuvirtide (Fuzeon, T20) in Patients With Enfuvirtide Resistance

Who this might be right for
HIV Infections
University of California, San Francisco 25
Large-scale testing (Phase 3)Active Not RecruitingNCT02362503
What this trial is testing

Attachment Inhibitor Comparison in Heavily Treatment Experienced Patients

Who this might be right for
HIV Infections
ViiV Healthcare 371

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation